Amgen Inc (NASDAQ:AMGN)
| 243.29 Delayed Data As of Sep 21 |  -4.53 / -1.83%Today’s Change | 177.05 Today|||52-Week Range 264.97 | +0.92% Year-to-Date |
Latest AMGN News | Press Releases
| Trump's Pep Talk Raises Vaccine Hopes: 4 Stocks to Watch Sep 21 / Zacks.com - Paid Partner Content | The 5 Undervalued Blue Chip High Dividend Growth Stocks You Need To Buy Now Sep 20 / Seeking Alpha - Paid Partner Content |
| Dow Jones Changes Could Impact Investor Portfolios Sep 21 / MotleyFool.com - Paid Partner Content | Sector Watch: More oncology events as cancer ETF breaks out Sep 20 / Seeking Alpha - Paid Partner Content |
| Should You Invest in the Invesco Dynamic Biotechnology Genome ETF (PBE)? Sep 21 / Zacks.com - Paid Partner Content | Amgen: Growing At A Reasonable Price Sep 20 / Seeking Alpha - Paid Partner Content |
| Amgen's sotorasib shows encouraging clinical benefit in KRAS G12C-mutant tumors Sep 21 / Seeking Alpha - Paid Partner Content | Where Will Amgen Be in 1 Year? Sep 19 / MotleyFool.com - Paid Partner Content |
| Moderna CEO: It's All or Nothing Sep 20 / GuruFocus News - Paid Partner Content | Seeking Alpha Catalyst Watch Sep 18 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 247.72 |
| Today’s open | 247.04 |
| Day’s range | 238.20 - 247.04 |
| Volume | 2,745,529 |
| Average volume (3 months) | 2,742,446 |
| Market cap | $145.1B |
Data as of 3:59pm ET, 09/21/2020
Growth & Valuation
| Earnings growth (last year) | +2.07% |
| Earnings growth (this year) | +6.39% |
| Earnings growth (next 5 years) | +7.07% |
| Revenue growth (last year) | -2.13% |
| P/E ratio | 19.9 |
| Price/Sales | 6.31 |
| Price/Book | 15.15 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GILDGilead Sciences | -0.84 | -1.29% |
| BIIBBiogen | -6.18 | -2.25% |
| ILMNIllumina Inc | -25.37 | -8.59% |
| MRNAModerna Inc | -0.61 | -0.87% |
Data as of 4:54pm ET, 09/21/2020
Financials
| Next reporting date | November 3, 2020 |
| EPS forecast (this quarter) | $3.80 |
| Annual revenue (last year) | $23.3B |
| Annual profit (last year) | $7.8B |
| Net profit margin | 33.71% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Thousand Oaks, California |
Forecasts
